Zobrazeno 1 - 10
of 4 671
pro vyhledávání: '"A. Thistlethwaite"'
Autor:
Lenka Stejskal, Angela Thistlethwaite, Fidel Ramirez-Bencomo, Smruti Rashmi, Odile Harrison, Ian M. Feavers, Martin C. J. Maiden, Ann Jerse, Grace Barnes, Oscar Chirro, James Chemweno, Eunice Nduati, Ana Cehovin, Christoph Tang, Eduard J. Sanders, Jeremy P. Derrick
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Development of a vaccine against gonorrhoea is a global priority, driven by the rise in antibiotic resistance. Although Neisseria gonorrhoeae (Ng) infection does not induce substantial protective immunity, highly exposed individuals may deve
Externí odkaz:
https://doaj.org/article/cd99a63b581e43b3a4aeb85b342e49be
Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis
Autor:
Hongryeol Park, Jian Song, Hyun-Woo Jeong, Max L. B. Grönloh, Bong Ihn Koh, Esther Bovay, Kee-Pyo Kim, Luisa Klotz, Patricia A. Thistlethwaite, Jaap D. van Buul, Lydia Sorokin, Ralf H. Adams
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Demyelination due to autoreactive T cells and inflammation in the central nervous system are principal features of multiple sclerosis (MS), a chronic and highly disabling human disease affecting brain and spinal cord. Here, we show that trea
Externí odkaz:
https://doaj.org/article/73b6422aec3343758220e17b6a05df69
Autor:
Chelsea S. Sawyer, Sally Taylor, Louise Carter, Melissa Stanworth, Michelle Davies, Fiona Thistlethwaite, Jo Taylor, Charlotte Eastwood, Janelle Yorke
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Our aim was to develop a validated Patient Reported Experience Measure (PREM) to capture patient and carer experience during participation in experimental cancer medicine trials (ECM): called PREM-ECM. Methods Mixed method design,
Externí odkaz:
https://doaj.org/article/ba449acd2ee04567936770f30e75b5d8
Autor:
E. Dowd, A. J. Manning, B. Orth-Lashley, M. Girard, J. France, R. E. Fisher, D. Lowry, M. Lanoisellé, J. R. Pitt, K. M. Stanley, S. O'Doherty, D. Young, G. Thistlethwaite, M. P. Chipperfield, E. Gloor, C. Wilson
Publikováno v:
Atmospheric Measurement Techniques, Vol 17, Pp 1599-1615 (2024)
Atmospheric methane (CH4) is the second-most-important anthropogenic greenhouse gas and has a 20-year global warming potential 82 times greater than carbon dioxide (CO2). Anthropogenic sources account for ∼ 60 % of global CH4 emissions, of which 20
Externí odkaz:
https://doaj.org/article/b47251203ecf4cf4a6fc9f267a4617c0
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 24, Pp 699-714 (2024)
Local stakeholders need information about areas exposed to potential flooding to manage increasing disaster risk. Moderate- and large-scale flood hazard mapping is often produced at a low spatial resolution, typically using only one source of floodin
Externí odkaz:
https://doaj.org/article/522d05337bd648f2a1ab2d883ddef0f4
The Bianchi groups ${\rm Bi}(d)={\rm PSL}(2,\mathcal{O}_d) < {\rm PSL}(2,\C)$ (where $\mathcal{O}_d$ denotes the ring of integers of $\Q (i\sqrt{d})$, with $d \geqslant 1$ squarefree) can be viewed as subgroups of ${\rm SO}(3,1)$ under the isomorphis
Externí odkaz:
http://arxiv.org/abs/2208.14499
Autor:
Reem Joukhadar, Yongjun Li, Rebecca Thistlethwaite, Kerrie L. Forrest, Josquin F. Tibbits, Richard Trethowan, Matthew J. Hayden
Publikováno v:
Frontiers in Plant Science, Vol 15 (2024)
IntroductionIn plant breeding, we often aim to improve multiple traits at once. However, without knowing the economic value of each trait, it is hard to decide which traits to focus on. This is where “desired gain selection indices” come in handy
Externí odkaz:
https://doaj.org/article/3918bd1d40254954a39760133f0dd675
Autor:
K.S. Shohdy, M. Pillai, K.S. Abbas, J. Allison, T. Waddell, E. Darlington, S. Mohammad, S. Hood, S. Atkinson, K. Simpson, D. Morgan, P. Nathan, E. Kilgour, C. Dive, F. Thistlethwaite
Publikováno v:
Immuno-Oncology and Technology, Vol 22, Iss , Pp 100712- (2024)
Background: Predictive biomarkers for immune checkpoint blockade in the second-line treatment of metastatic renal cell carcinoma (mRCC) are lacking. Materials and methods: Patients with histologically confirmed RCC who started nivolumab after at leas
Externí odkaz:
https://doaj.org/article/9999ea2b6c8b4d79baae2997da635028
Autor:
Liu, Xiangning, Thistlethwaite, Sian, Kholiya, Rohit, Pierscianowski, Jacob, Saliba, Kevin J., Auclair, Karine
Publikováno v:
In European Journal of Medicinal Chemistry 15 December 2024 280